{"id":50884,"date":"2026-08-04T17:00:00","date_gmt":"2026-08-04T15:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=2c944666bd0ab9dfb105a250e7ddfb27"},"modified":"2026-08-04T17:00:00","modified_gmt":"2026-08-04T15:00:00","slug":"twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635c4","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=50884","title":{"rendered":"Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)"},"content":{"rendered":"

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (\u201cTwist\u201d or the \u201cCompany\u201d), a mid-cap growth and value biotech company, today announced that a total of 44,434 restricted stock units (\u201cRSUs\u201d) will be granted to 24 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist\u2019s Amended and Restated Inducement Equity Incentive Plan and related form of restricted stock unit award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).<\/p><\/a><\/a>

\nThe inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Twist, pursuant to Nasdaq Listing Rule 5635(c)(4).<\/p>

\nA portion of the 44,434 RSUs vest over a 48-month period for each employee as follows: 25% vests on the one-year anniversary of the applicable vesting commencement date (the \u201cVesting Commencement Date\u201d), and 1\/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date thereafter, subject to the employee\u2019s continued service through each vesting date. A portion of the 44,434 RSUs vest over a 48-month period for each employee as follows: 1\/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date, subject to the employee\u2019s continued service through each vesting date.<\/p>

\nAbout Twist Bioscience Corporation<\/b><\/p>

\nAt Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.<\/p>

\nWe drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal \u2013 more experiments, more iterations, more chances for remarkable discoveries.<\/p>

\nTogether, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all. For more information about our products and services, please visit www.twistbioscience.com<\/a>.<\/p>

\nFollow us on LinkedIn<\/a> | X<\/a> | YouTube<\/a> | Instagram<\/a> | Bluesky<\/a><\/p> Contacts<\/b>

\nFor Investors:<\/b>Angela Bitting\nSVP, Corporate Affairs\n925-202-6211\nabitting@twistbioscience.com<\/a><\/p>

\nFor Media:<\/b>Amanda Houlihan\nCommunications Manager\n774-265-5334\nahoulihan@twistbioscience.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (\u201cTwist\u201d or the \u201cCompany\u201d), a mid-cap growth and value biotech company, today announced that a total of 44,43…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-50884","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50884"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50884\/revisions"}],"predecessor-version":[{"id":50885,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50884\/revisions\/50885"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}